Breen returns to CEO post at DuPont as Doyle departs company in executive shake-up

621
Breen
Advertisement

Koch takes CFO post as Desmond moves on

Edward Breen has returned to the post of CEO of DuPont Co. after a difficult year for the company,  which was spun off from DowDuPont last year.

Breen, who will continue to the post of Executive Chairman will be joined by Lori D. Koch, Vice President of Investor Relations and Corporate Financial Planning and Analysis who is now  Chief Financial Officer.

Both appointments are effective immediately.   

Marc Doyle and Jeanmarie Desmond, who have served as CEO and CFO respectively, will leave  the company.

Advertisement

“While we made some progress in 2019, we did not meet our own expectations and we now need to move aggressively to secure our foundation for growth,” said Breen. “We have solid businesses, but, as we discussed on our recent earnings call, we need to accelerate operational improvement and make sure we are taking appropriate action to deliver on our commitments for the year.

Breen helped to engineer the sale of the industrial biosciences unit

Lori Koch will be a great partner in this effort. She has delivered consistently excellent results across a substantial career as a finance leader at DuPont and has significant knowledge of our businesses. Lori has demonstrated her expertise in developing and executing the right financial strategy to support the achievement of our business objectives,” said Breen.

“Since he first assumed the Chairman and CEO role of DuPont in 2015, Ed Breen led the company through an extensive transformation to further unlock the potential of its distinctive capabilities, innovative portfolio and deep customer relationships,” said Alexander M. Cutler, DuPont’s lead independent director. “After careful consideration, the Board concluded now is the right time to make these leadership changes, including restoring Ed to the chief executive role to draw more directly on his substantial operating experience. The board is confident that together Ed and Lori will improve operational performance and ensure DuPont fully delivers on its significant potential for long-term value creation.”

“The Board and I deeply appreciate Marc and Jean’s significant contributions over decades of service to the company,” said Breen. “Most recently, they led the company through a period of important transition, and we are grateful for their dedication to DuPont over the course of their careers.

“I continue to have enormous confidence in this company and in our team. Delivering on our commitments and realizing our full potential is my personal top priority. Consistent with this I will be transitioning from the Corteva board to focus fully on our work at DuPont,” Breen said.

The company will continue to advance the initiatives announced on its fourth quarter and year-end 2019 conference call to assure that its organizational and cost structures are right sized to reflect the ongoing portfolio changes. Nick Fanandakis, former DuPont CFO, will serve as Senior Advisor to the CEO with a focus on driving the restructuring effort. 

Over a 17-year career at DuPont, Lori Koch has held finance leadership roles with increasing responsibility spanning business units, the science and technology organization and corporate functions.

She led finance for several multi-billion-dollar business units including Packaging & Industrial Polymers, Performance Polymers and Performance Materials before becoming head of Investor Relations and Corporate Financial Planning and Analysis.

Breen has served as the Executive Chairman of DuPont since the separation in June 2019 and previously served as Chief Executive Officer of DowDuPont since 2017. Prior to the merger of DuPont and The Dow Chemical Company, Breen was Chairman and CEO of DuPont since 2015

 

Advertisement
Advertisement